Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$8.16 - $13.01 $1,240 - $1,977
-152 Reduced 1.1%
13,618 $164,000
Q2 2023

Aug 14, 2023

SELL
$8.63 - $12.53 $7,706 - $11,189
-893 Reduced 6.09%
13,770 $145,000
Q1 2023

May 15, 2023

SELL
$9.32 - $15.06 $14,846 - $23,990
-1,593 Reduced 9.8%
14,663 $144,000
Q4 2022

Feb 14, 2023

SELL
$12.5 - $18.13 $14,262 - $20,686
-1,141 Reduced 6.56%
16,256 $239,000
Q3 2022

Nov 14, 2022

SELL
$11.57 - $15.59 $11,917 - $16,057
-1,030 Reduced 5.59%
17,397 $211,000
Q2 2022

Aug 15, 2022

BUY
$8.45 - $14.84 $38,253 - $67,180
4,527 Added 32.57%
18,427 $258,000
Q1 2022

May 13, 2022

BUY
$11.38 - $21.88 $158,182 - $304,132
13,900 New
13,900 $198,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $55.4M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.